Are you Dr. Hauser?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 70 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
350 Parnassus Ave 908
San Francisco, CA 94143Phone+1 415-476-9211Fax+1 415-514-2443
Summary
- Dr. Stephen Hauser, MD is a board certified neurologist in San Francisco, California. He is currently licensed to practice medicine in California and Massachusetts. He is affiliated with UCSF Medical Center and San Francisco VA Medical Center.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1977 - 1983
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1975 - 1977
Harvard Medical SchoolClass of 1975
Certifications & Licensure
CA State Medical License 1992 - 2024
MA State Medical License 1987 - 1997- American Board of Internal Medicine Internal Medicine
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1999
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 374 citationsTreatment of Multiple Sclerosis: A ReviewStephen L. Hauser, Bruce A.C. Cree
The American Journal of Medicine. 2020-12-01 - 121 citationsKIRCD8T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19.Jing Li, Maxim Zaslavsky, Yapeng Su, Jing Guo, Michael J Sikora
Science. 2022-04-15 - 517 citationsOcrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trialLudwig Kappos, David Kb Li, Peter A. Calabresi, Paul O'Connor, Amit Bar-Or
Lancet. 2011-11-19
Authored Content
- Ofatumumab Versus Teriflunomide in Multiple SclerosisAugust 2020
- Ofatumumab Versus Teriflunomide in Multiple SclerosisAugust 2020
- Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical TrialsJune 2020
- Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients with Primary Progressive Multiple Sclerosis in the ORATORIO TrialMay 2020
- Progress in Multiple Sclerosis ResearchMay 2020
- Progress in Multiple Sclerosis ResearchMay 2020
- Join now to see all
Press Mentions
How Progressive Multiple Sclerosis Differs from Relapsing-Remitting MSAugust 27th, 2024- The 42 Best Books and Podcasts on Health and Science to Check Out This SummerJune 25th, 2024
- Autoantibodies Predict Multiple Sclerosis Years in AdvanceApril 22nd, 2024
- Join now to see all
Grant Support
- Educating Physician-Neuroscientists: The R25 At UCSFNational Institute Of Neurological Disorders And Stroke2010–2012
- Gene Linkage Study Of Multiple Sclerosis Sibling PairsNational Institute Of Neurological Disorders And Stroke1993–2012
- A Haplotype MAP For Multiple SclerosisNational Institute Of Neurological Disorders And Stroke2005–2011
- Multiple Sclerosis StudyNational Institute Of Allergy And Infectious Diseases2005–2009
- Molecular Genetics Of HLA And DiseaseNational Institute Of Allergy And Infectious Diseases2005–2009
- Administrative CoreNational Institute Of Allergy And Infectious Diseases2005
- Mechanisms Of EAENational Institute Of Allergy And Infectious Diseases1997–2005
- Annual MRI, MTR And Hmrsi In Healthy Controls And PpmsNational Institute Of Neurological Disorders And Stroke2000–2001
- Experimental Allergic Encephalomyelitis (EAE) In Common MarmosetNational Center For Research Resources1997
- Mechanisms Of EAENational Institute Of Neurological Disorders And Stroke1992–1995
- Gene Linkage Study Of Multiple Sclerosis Sibling PairsNational Institute Of Neurological Disorders And Stroke1989–1992
- Neurite-Promoting Factors From Muscle And AutoimmunityNational Institute Of Neurological Disorders And Stroke1986–1988
